Cargando…

Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports

INTRODUCTION: Large deletions of the NF1 gene and its flanking regions are frequently associated with a severe clinical manifestation. Different types of gross NF1 deletion have been identified that are distinguishable both by their size and the number of genes included within the deleted regions. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogt, Julia, Nguyen, Rosa, Kluwe, Lan, Schuhmann, Martin, Roehl, Angelika C, Mußotter, Tanja, Cooper, David N, Mautner, Victor-Felix, Kehrer-Sawatzki, Hildegard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269400/ https://www.ncbi.nlm.nih.gov/pubmed/22151963 http://dx.doi.org/10.1186/1752-1947-5-577

Ejemplares similares

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions
por: Mußotter, Tanja, et al.
Publicado: (2012)

Emerging genotype–phenotype relationships in patients with large NF1 deletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2017)

Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

Clinical characterization of children and adolescents with NF1 microdeletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2020)

Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2021)

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2016)

Exploring the potential relevance of human-specific genes to complex disease
por: Cooper, David N, et al.
Publicado: (2011)

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021)

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease
por: Cooper, David N., et al.
Publicado: (2013)

SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints
por: Vogt, Julia, et al.
Publicado: (2014)

Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients
por: Lammert, Marge, et al.
Publicado: (2005)

Distinct sequence features underlie microdeletions and gross deletions in the human genome
por: Qi, Mengling, et al.
Publicado: (2022)

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality
por: Gugel, Isabel, et al.
Publicado: (2020)

Identification of an NF1 Microdeletion with Optical Genome Mapping
por: Büki, Gergely, et al.
Publicado: (2023)

Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults
por: Gugel, Isabel, et al.
Publicado: (2018)

Co‐occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1
por: Kehrer‐Sawatzki, Hildegard, et al.
Publicado: (2018)

Cross-comparison of the genome sequences from human, chimpanzee, Neanderthal and a Denisovan hominin identifies novel potentially compensated mutations
por: Zhang, Guojie, et al.
Publicado: (2011)

Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2021)

Gene synteny comparisons between different vertebrates provide new insights into breakage and fusion events during mammalian karyotype evolution
por: Kemkemer, Claus, et al.
Publicado: (2009)

Presenting symptoms in children with neurofibromatosis type 2
por: Gugel, Isabel, et al.
Publicado: (2020)

Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
por: Gugel, Isabel, et al.
Publicado: (2019)

C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis
por: Farschtschi, Said C., et al.
Publicado: (2020)

Age at Onset and Presenting Symptoms of Neurofibromatosis Type 2 as Prognostic Factors for Clinical Course of Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2020)

Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular Schwannomas
por: Gugel, Isabel, et al.
Publicado: (2019)

Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplications
por: Wolfe, Kate, et al.
Publicado: (2018)

Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients
por: Frahm, Silke, et al.
Publicado: (2004)

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
por: Well, Lennart, et al.
Publicado: (2020)

Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
por: Reuss, David E., et al.
Publicado: (2013)

Evolutionary History and Genome Organization of DUF1220 Protein Domains
por: O’Bleness, Majesta S., et al.
Publicado: (2012)

Further phenotypic delineation of subtelomeric (terminal) 4q deletion with emphasis on intracranial and reproductive anatomy
por: Sills, Eric Scott, et al.
Publicado: (2007)

Severe Phenotype in Patients with Large Deletions of NF1
por: Pacot, Laurence, et al.
Publicado: (2021)

Delineation of 2q32q35 Deletion Phenotypes: Two Apparent “Proximal” and “Distal” Syndromes
por: Mc Cormack, Adrian, et al.
Publicado: (2013)

Case Report: Mosaicism of a novel nonsense variant in the neurofibromin gene underlies a mosaic generalized NF1 phenotype
por: Kwong, Hui Li, et al.
Publicado: (2021)

Further delineation of the phenotype caused by a novel large homozygous deletion of GRID2 gene in an adult patient
por: Taghdiri, Maryam, et al.
Publicado: (2019)

Preclinical Assessment of the Anticancer Drug Response of Plexiform Neurofibroma Tissue Using Primary Cultures
por: Jiang, Wei, et al.
Publicado: (2015)

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1
por: Nguyen, Rosa, et al.
Publicado: (2012)

Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes
por: Rahman, Muhammad M., et al.
Publicado: (2019)

Genomic and phenotypic delineation of congenital microcephaly
por: Shaheen, Ranad, et al.
Publicado: (2018)

Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
por: Spyra, Melanie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_86vifq4pbjc9c31pqotk8201id